Programs Data Science Consultant (Remote)

Key Skills

Biomedical Imaging, Deep Learning, Effective communication skills, Python Programming, R Programming, Regression Analysis, RNA-seq Data processing, Statistical modeling

Job Description

The Role: BigHat Biosciences is seeking an exceptional data science consultant to accelerate our selection of therapeutic programs. 

This role reports directly to the Programs Data Science Lead. This role has the potential to grow into a full-time position. 

Key Responsibilities

The goals and responsibilities of this position include: 

• Development of databases and pipelines for the identification of therapeutic targets from gene and protein expression data. 
• Prioritization of co-expressed targets for utilization in therapeutics.
• Identification of areas of major therapeutic opportunity across a diverse set of diseases.

About You

• PhD or current PhD student in a relevant domain [Computational Biology, Statistics, Computer Science, Bioengineering, or similar].
• Experience with bulk and single cell RNAseq data and protein expression data, including: working with public data sources (i.e. TCGA, Human Protein Atlas, Human Cell Atlas, GTEx), identifying gene signatures of disease.
• Competency in Python, R, or similar programming languages.
• Excellent communication skills, experience interacting with diverse scientific teams. 
• Enjoys a fast paced environment and executing across multiple projects.

About BigHat Biosciences

BigHat Biosciences designs safer, more effective biologic therapies for patients using machine learning and synthetic biology.

BigHat integrates a wet lab for high-speed characterization with machine learning technologies to guide the search for better antibodies. We apply these design capabilities to develop new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases.

BigHat is a Series B biotech outside San Francisco with a team-oriented, inclusive, and family-friendly culture. Our broad pipeline of wholly-owned and partnered therapeutic programs span many disparate indications with high unmet need, such as cancer, inflammation, and infectious disease. BigHat has raised >$100M from top investors, including Section 32, a16z, and 8VC.